Sri Krishna Mukkamala, MD
Hospitalist · Cumming, GANPI 1710184148
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $175,854 of the $239,809 with a category attached, or 73.3%. Regeneron Healthcare Solutions, Inc. accounts for 75.7% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $58,220 and has fallen 54.1% since, to $26,728 in 2025. Among hospitalist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 471 payments — averaging $509.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$182K
- Genentech USA, Inc.$22K
- Novartis$11K
- Alimera Sciences, Inc.$8K
- US Retina LLC$6K
- Nidek Incorporated$3K
- plus $7K from 22 others
Across 80 payments — averaging $36.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$3K
What the payments were for
- Consulting fees$22,82410%
- Speaking & faculty fees$175,85473%
- Travel & lodging$22,0859%
- Food & beverage$13,3236%
- Ownership interest$5,7232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 213 | $181,635 |
| Genentech USA, Inc. | 52 | $21,887 |
| Novartis | 21 | $11,261 |
| Alimera Sciences, Inc. | 45 | $8,462 |
| US Retina LLC | 6 | $5,723 |
| Nidek Incorporated | 1 | $3,492 |
| Notal Vision, Inc. | 8 | $2,090 |
| Astellas Pharma US Inc | 23 | $785 |
| AbbVie(2 entities) | 24 | $684 |
| Apellis Pharmaceuticals, Inc. | 18 | $585 |
| Eyepoint US, Inc. | 9 | $484 |
| ANI Pharmaceuticals, Inc. | 12 | $465 |
| Carl Zeiss Meditec USA, Inc. | 4 | $396 |
| Alcon | 5 | $332 |
| NEW World Medical,inc. | 1 | $210 |
| Bausch & Lomb Americas Inc. | 4 | $192 |
| Regeneron | 2 | $178 |
| Coherus Oncology, Inc. | 8 | $176 |
| Sight Sciences, Inc. | 1 | $147 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| Rxsight Inc | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $123 |
| Biogen | 4 | $75 |
| Sandoz | 2 | $67 |
| Halozyme Inc | 2 | $52 |
| Teleflex LLC | 1 | $25 |
| Amgen | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$118,677
- EYLEA HD$59,646
- VABYSMO$20,443
- Iluvien$7,723
- SUSVIMO$3,909
- Lucentis$2,520
- BEOVU$2,239
- YUTIQ$2,102
- DEXYCU$250
- Kahook Dual Blade$210
- Clearpath$210
- Ahmed Glaucoma Valve$210
- Streamline$210
- Via360$210
- OZURDEX$149
- OMNI(R) SURGICAL SYSTEM (US)$147
- XIPERE$145
- VISUDYNE$145
- Constellation$139
- Clarus 700$133
How this compares
$239,809 in reported general payments places this provider in the 95th percentile of 812 hospitalist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 105 | $4,909 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 14 | $3,037 |
| Brimonidine Tartrate | 38 | $2,895 |
| Atropine Sulfate | 60 | $2,040 |
| Latanoprost | 200 | $1,909 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $451 |
| Ciprofloxacin Hcl | 26 | $374 |
| Timolol Maleate | 33 | $344 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 52 | $315 |
| Dorzolamide Hcl | 11 | $291 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Cumming
- Annie ParkCanton$19K
- Philippa AmeneGainesville$11K
- Anna SikodGainesville$9K
- Emilio LacayoAtlanta$9K
- Mukesh KumarAtlanta$6K
- Stanley SmithNewnan$6K
- Alfred RathinamAthens$6K
- Amaka EzimoraAtlanta$6K
- Anum NiaziMacon$5K
- Pramod KakaralaAtlanta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.